Yelin Lapidot Holdings Management Ltd. Chemomab Therapeutics Ltd. Transaction History
Yelin Lapidot Holdings Management Ltd.
- $607 Billion
- Q3 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 809,717 shares of CMMB stock, worth $1.36 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
809,717Holding current value
$1.36 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding CMMB
# of Institutions
17Shares Held
4.55MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$2.93 Million0.06% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.21MShares$2.04 Million0.35% of portfolio
-
Morgan Stanley New York, NY402KShares$675,8160.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$358,4980.06% of portfolio
-
Two Sigma Securities, LLC New York, NY39.9KShares$67,0970.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $19.2M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...